Clinical trial
DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in…
NCT00220090 · Rottapharm, Industry · Completed
Key facts
| NCT number | NCT00220090 |
|---|---|
| Title | DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS) |
| Official title | A 24-wk, Prospective, d/b, Placebo Controlled, Parallel Group, Multicenter, Randomized/Withdrawal Efficacy and Safety Study of Dexloxiglumide for the Relief of Symptoms in Patients With Constipation-Predominant Irritable Bowel Syndrome |
| Lead sponsor | Rottapharm, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | dexloxiglumide |
| Start date | Jul 1, 2003 |
| Primary completion | Sep 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | May 14, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: